✦ LIBER ✦

The influence of histologic type on survival in non-Hodgkin's lymphoma

✍ Scribed by M. Barcos; R. Herrmann; J. W. Pickren; C. Naeher; Tin Han; L. Stutzman; E. S. Henderson

Publisher: John Wiley and Sons
Year: 1981
Tongue: English
Weight: 631 KB
Volume: 47
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19810615)47:12<2894::aid-cncr2820471224>3.0.co;2-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The influence of histologic type on the

The influence of histologic type on the incidence and duration of response in non-Hodgkin's lymphoma

✍ R. Herrmann; M. Barcos; L. Stutzman; D. Walsh; A. Freeman; J. Sokal; E. S. Hende 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 825 KB

A group of 227 cases of non-Hodgkin's lymphoma included seven favorable and four unfavorable histologic classes with collective median survival times of 83 and 16 months, respectively. The favorable group included three follicular subgroups (cleaved, mixed, and large noncleaved) and four diffuse cla

Histologic subtypes and survival of Chin

Histologic subtypes and survival of Chinese patients with non-Hodgkin's lymphomas

✍ Raymond Liang; Shee-Loong Loke; Faith C. S. Ho; Edmond Chiu; Tai-Kwong Chan; Dav 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 524 KB

Survival of the older patient compared w

Survival of the older patient compared with the younger patient with hodgkin's disease. Influence of histologic type, staging, and treatment

✍ Ann Walker; Elinor R. Schoenfeld; James T. Lowman; Curtis J. Mettlin; Julie Macm 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 612 KB

Treatment of aggressive Non-Hodgkin's ly

Treatment of aggressive Non-Hodgkin's lymphoma in the elderly

✍ Nicolas Novitzky; Helen S. King; Carol Johnson; Peter Jacobs 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 643 KB

Chemotherapy followed by consolidation r

Chemotherapy followed by consolidation radiation therapy for the treatment of clinical stage ii aggressive histologic type non-hodgkin's lymphoma

✍ Michael J. O'Connell; David P. Harrington; John D. Earle; Gerhard J. Johnson; Jo 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 509 KB

Sixty-three eligible patients with Ann Arbor clinical Stage I1 or IIE aggressive histologic type non-Hodgkin's lymphomas received combination chemotherapy (cyclophosphamide, doxorubicin, vincristine, and prednisone (COPAJ) as the primary treatment technique. Moderate-dose radiation therapy (2500 to

The influence of histologic subtype on t

The influence of histologic subtype on toxicity and response to chemotherapy in non-Hodgkin-s lymphoma an eastern cooperative oncology group study utilizing the BCVP regimen

✍ Martin M. Oken; William G. Costello; Gerhard J. Johnson; Raymond E. Lenhard; Edi 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 605 KB